• Je něco špatně v tomto záznamu ?

Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring

P. Darebna, P. Novak, R. Kucera, O. Topolcan, M. Sanda, R. Goldman, P. Pompach,

. 2017 ; 153 (-) : 44-52. [pub] 20160916

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017034

Alternations in the glycosylation of proteins have been described in connection with several cancers, including hepatocellular carcinoma (HCC) and colorectal cancer. Analytical tools, which use combination of liquid chromatography and mass spectrometry, allow precise and sensitive description of these changes. In this study, we use MRM and FT-ICR operating in full-MS scan, to determine ratios of intensities of specific glycopeptides in HCC, colorectal cancer, and liver metastasis of colorectal cancer. Haptoglobin, hemopexin and complement factor H were detected after albumin depletion and the N-linked glycopeptides with fucosylated glycans were compared with their non-fucosylated forms. In addition, sialylated forms of an O-linked glycopeptide of hemopexin were quantified in the same samples. We observe significant increase in fucosylation of all three proteins and increase in bi-sialylated O-glycopeptide of hemopexin in HCC of hepatitis C viral (HCV) etiology by both LC-MS methods. The results of the MRM and full-MS scan FT-ICR analyses provide comparable quantitative readouts in spite of chromatographic, mass spectrometric and data analysis differences. Our results suggest that both workflows allow adequate relative quantification of glycopeptides and suggest that HCC of HCV etiology differs in glycosylation from colorectal cancer and liver metastasis of colorectal cancer. SIGNIFICANCE: The article compares N- and O-glycosylation of several serum proteins in different diseases by a fast and easy sample preparation procedure in combination with high resolution Fourier transform ion cyclotron resonance mass spectrometry. The results show successful glycopeptides relative quantification in a complex peptide mixture by the high resolution instrument and the detection of glycan differences between the different types of cancer diseases. The presented method is comparable to conventional targeted MRM approach but allows additional curation of the data.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017034
003      
CZ-PrNML
005      
20180515103317.0
007      
ta
008      
180515s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jprot.2016.09.004 $2 doi
035    __
$a (PubMed)27646713
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Darebna, Petra $u Department of Biochemistry, Faculty of Sciences, Charles University, Prague, Czech Republic.
245    10
$a Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring / $c P. Darebna, P. Novak, R. Kucera, O. Topolcan, M. Sanda, R. Goldman, P. Pompach,
520    9_
$a Alternations in the glycosylation of proteins have been described in connection with several cancers, including hepatocellular carcinoma (HCC) and colorectal cancer. Analytical tools, which use combination of liquid chromatography and mass spectrometry, allow precise and sensitive description of these changes. In this study, we use MRM and FT-ICR operating in full-MS scan, to determine ratios of intensities of specific glycopeptides in HCC, colorectal cancer, and liver metastasis of colorectal cancer. Haptoglobin, hemopexin and complement factor H were detected after albumin depletion and the N-linked glycopeptides with fucosylated glycans were compared with their non-fucosylated forms. In addition, sialylated forms of an O-linked glycopeptide of hemopexin were quantified in the same samples. We observe significant increase in fucosylation of all three proteins and increase in bi-sialylated O-glycopeptide of hemopexin in HCC of hepatitis C viral (HCV) etiology by both LC-MS methods. The results of the MRM and full-MS scan FT-ICR analyses provide comparable quantitative readouts in spite of chromatographic, mass spectrometric and data analysis differences. Our results suggest that both workflows allow adequate relative quantification of glycopeptides and suggest that HCC of HCV etiology differs in glycosylation from colorectal cancer and liver metastasis of colorectal cancer. SIGNIFICANCE: The article compares N- and O-glycosylation of several serum proteins in different diseases by a fast and easy sample preparation procedure in combination with high resolution Fourier transform ion cyclotron resonance mass spectrometry. The results show successful glycopeptides relative quantification in a complex peptide mixture by the high resolution instrument and the detection of glycan differences between the different types of cancer diseases. The presented method is comparable to conventional targeted MRM approach but allows additional curation of the data.
650    _2
$a hepatocelulární karcinom $x diagnóza $x etiologie $x sekundární $7 D006528
650    _2
$a kolorektální nádory $x diagnóza $x etiologie $x patologie $7 D015179
650    _2
$a cyklotrony $7 D017357
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a Fourierova analýza $7 D005583
650    _2
$a glykopeptidy $x analýza $7 D006020
650    _2
$a glykosylace $7 D006031
650    _2
$a hepatitida C $x komplikace $x virologie $7 D006526
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x diagnóza $x etiologie $x sekundární $7 D008113
650    _2
$a hmotnostní spektrometrie $x přístrojové vybavení $x metody $7 D013058
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Novak, Petr $u Institute of Microbiology v.v.i., Czech Academy of Sciences, Prague, Czech Republic; Department of Biochemistry, Faculty of Sciences, Charles University, Prague, Czech Republic.
700    1_
$a Kucera, Radek $u Laboratory of Immunoanalysis, Faculty Hospital in Pilsen, Pilsen, Czech Republic.
700    1_
$a Topolcan, Ondrej $u Laboratory of Immunoanalysis, Faculty Hospital in Pilsen, Pilsen, Czech Republic.
700    1_
$a Sanda, Miloslav $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
700    1_
$a Goldman, Radoslav $u Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
700    1_
$a Pompach, Petr $u Institute of Microbiology v.v.i., Czech Academy of Sciences, Prague, Czech Republic; Department of Biochemistry, Faculty of Sciences, Charles University, Prague, Czech Republic. Electronic address: pompach@biomed.cas.cz.
773    0_
$w MED00166847 $t Journal of proteomics $x 1876-7737 $g Roč. 153, č. - (2017), s. 44-52
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27646713 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180515103451 $b ABA008
999    __
$a ok $b bmc $g 1300658 $s 1013874
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 153 $c - $d 44-52 $e 20160916 $i 1876-7737 $m Journal of proteomics $n J Proteomics $x MED00166847
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace